{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:51:53Z","timestamp":1791647513648,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jaip.2017.10.016","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T23:16:03Z","timestamp":1512170163000},"page":"1238-1242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Successful Intravenous Immunoglobulin Treatment in Pediatric Severe DRESS Syndrome"],"prefix":"10.1016","volume":"6","author":[{"given":"Nufar","family":"Marcus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Smuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Almog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Prais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Straussberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Scheuerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.10.016_bib1","doi-asserted-by":"crossref","first-page":"693.e1","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: Part I. Clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2017.10.016_bib2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2017.10.016_bib3","first-page":"74","article-title":"Ibuprofen induced DRESS syndrome in a child","volume":"53","author":"Koca","year":"2016","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jaip.2017.10.016_bib4","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1111\/pde.12935","article-title":"Probable griseofulvin-induced drug reaction with eosinophilia and systemic symptoms in a child","volume":"33","author":"Smith","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2017.10.016_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/scitranslmed.3001116","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response","volume":"2","author":"Picard","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaip.2017.10.016_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00023210-200216030-00006","article-title":"Anticonvulsant hypersensitivity syndrome in children","volume":"16","author":"Verrotti","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jaip.2017.10.016_bib7","first-page":"556","article-title":"Clinical features of drug-induced hypersensitivity syndrome in 38 patients","volume":"20","author":"Um","year":"2010","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2017.10.016_bib8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaad.2014.10.032","article-title":"Therapeutic management of DRESS: a retrospective study of 38 cases","volume":"72","author":"Funck-Brentano","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2017.10.016_bib9","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1468-3083.2008.02585.x","article-title":"Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan","volume":"22","author":"Chiou","year":"2008","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2017.10.016_bib10","doi-asserted-by":"crossref","first-page":"709.e1","DOI":"10.1016\/j.jaad.2013.01.032","article-title":"DRESS syndrome: Part II. Management and therapeutics","volume":"68","author":"Husain","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2017.10.016_bib11","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.jaad.2011.06.038","article-title":"Successful treatment of lamotrigine-associated drug hypersensitivity syndrome with intravenous IgG","volume":"66","author":"Comfere","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2017.10.016_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.SMJ.0000054501.05278.5F","article-title":"Anticonvulsant hypersensitivity syndrome: treatment with corticosteroids and intravenous immunoglobulin","volume":"97","author":"Mostella","year":"2004","journal-title":"South Med J"},{"key":"10.1016\/j.jaip.2017.10.016_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2340\/00015555-1168","article-title":"High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome","volume":"92","author":"Kito","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2017.10.016_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/jamadermatol.2013.1949","article-title":"A\u00a0case of recalcitrant DRESS syndrome with multiple autoimmune sequelae treated with intravenous immunoglobulins","volume":"149","author":"Singer","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2017.10.016_bib15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archderm.148.4.dlt120002-c","article-title":"Poor benefit\/risk balance of intravenous immunoglobulins in DRESS","volume":"148","author":"Joly","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2017.10.016_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaip.2013.11.008","article-title":"Clinical and laboratory improvement after intravenous immunoglobulin in drug reaction with eosinophilia and systemic symptoms","volume":"2","author":"Galv\u00e3o","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.10.016_bib17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2017.10.016_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/00015550410024094","article-title":"Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells","volume":"85","author":"Hashizume","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2017.10.016_bib19","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2017.10.016_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S0365-05962012000300013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS)\/drug-induced hypersensitivity syndrome (DIHS): a review of current concepts","volume":"87","author":"Criado","year":"2012","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaip.2017.10.016_bib21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/archderm.140.2.183","article-title":"Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia","volume":"140","author":"Kano","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2017.10.016_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.alit.2017.06.001","article-title":"The thymus and activation-regulated chemokine (TARC) level in serum at an early stage of a drug eruption is a prognostic biomarker of severity of systemic inflammation","volume":"67","author":"Komatsu-Fujii","year":"2018","journal-title":"Allergol Int"},{"issue":"Suppl","key":"10.1016\/j.jaip.2017.10.016_bib23","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology","volume":"117","author":"Orange","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.10.016_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tox.2004.12.013","article-title":"Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome","volume":"209","author":"Kano","year":"2005","journal-title":"Toxicology"},{"issue":"Suppl 2","key":"10.1016\/j.jaip.2017.10.016_bib25","first-page":"s33","article-title":"Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune mediated neuropathies","volume":"59","author":"Brannagan","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jaip.2017.10.016_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pediatrneurol.2010.03.010","article-title":"Anticonvulsant hypersensitivity syndrome treated with intravenous immunoglobulin","volume":"43","author":"Dredge","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jaip.2017.10.016_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/08830738060210051301","article-title":"Treatment of anticonvulsant hypersensitivity syndrome with intravenous immunoglobulins and corticosteroids","volume":"21","author":"Prais","year":"2006","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.jaip.2017.10.016_bib28","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1542\/peds.107.1.e14","article-title":"Successful treatment of antiepileptic drug hypersensitivity syndrome with intravenous immune globulin","volume":"107","author":"Scheuerman","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2017.10.016_bib29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1440-1754.2005.00591.x","article-title":"Hepatic failure in a child with anti-epileptic hypersensitivity syndrome","volume":"41","author":"Li","year":"2005","journal-title":"J\u00a0Paediatr Child Health"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817308541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817308541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:15:05Z","timestamp":1761974105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817308541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2213219817308541"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.10.016","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful Intravenous Immunoglobulin Treatment in Pediatric Severe DRESS Syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}